Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Therapeutic Category
Antibiotic, Anti-Inflammatories, Ophthalmology, Antibacterials
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹125/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Gatitrip FL Eye Drop is a dual-action formulation combining Flurbiprofen (0.03% w/v), a nonsteroidal anti-inflammatory drug (NSAID), and Gatifloxacin (0.3% w/v), an antibiotic, to provide comprehensive treatment for various eye infections and inflammation.
This eye drop is primarily indicated for the treatment of ocular inflammation associated with post-operative cataract surgery and for preventing and treating eye infections. Flurbiprofen works by reducing inflammation, pain, and swelling, while Gatifloxacin combats bacterial infections by inhibiting bacterial DNA synthesis, effectively treating eye infections caused by susceptible organisms. This combination makes Gatitrip FL Eye Drop an effective choice for patients undergoing eye surgery or experiencing eye infections and inflammation.
It is used under medical supervision to manage the symptoms of ocular conditions and infections. The dual action of both the anti-inflammatory and antibiotic properties provides fast relief and minimizes the risk of complications such as infection after eye surgery.
Temporary burning, stinging, or blurred vision may occur. Rarely, allergic reactions like redness or itching in the eyes can happen.
Treatment of ocular inflammation and bacterial infections following cataract surgery.
Do not use if allergic to any of the ingredients. Consult your doctor before use if pregnant or breastfeeding.
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
Composition : Ofloxacin (0.3% w/v) Eye Ear Drops
Composition : Tobramycin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Flurazepam 10mg Capsule is a benzodiazepine hypnotic used for insomnia and severe sleep disorders, making it a CNS (central nervous system) segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from demand in psychiatry, neurology, and general physician prescriptions for short-term or chronic insomnia management. It is commonly prescribed for patients with significant sleep disturbances requiring sedative therapy.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Flurazepam Capsule with monopoly rights, quality CNS formulations, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from consistent prescription demand in sleep disorder management and psychiatry-related therapy cycles when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this CNS formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.